Finance

Lists
Why is PIII down ९.१४%?
Dive Deeper
PIII:NASDAQ
P3 Health Partners Inc
US$ १.६९
-९.१४%
(-०.१७) 1D
US$ १.६९
०.००% (०.००)
After hours
Closed: नोभेम्बर २०, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PIII...
Open
US$ १.८८
High
US$ १.८८
Low
US$ १.६३
Mkt. cap
१.२३ करोड
Avg. vol.
४६.७९ हजार
Volume
२३.२६ हजार
52-wk high
US$ १६.८९
52-wk low
US$ १.५२
EPS
-US$ २३.४४
Beta
१.८१
Shares outstanding
४०.१६ लाख
No. of employees
३२०
Open
US$ १.८८
High
US$ १.८८
Low
US$ १.६३
Mkt. cap
१.२३ करोड
Avg. vol.
४६.७९ हजार
Volume
२३.२६ हजार
52-wk high
US$ १६.८९
52-wk low
US$ १.५२
EPS
-US$ २३.४४
Beta
१.८१
Shares outstanding
४०.१६ लाख
No. of employees
३२०
News stories
From web sources and news partners
FOREX.com
FOREX.com
·
२१ मिनेट पहिले
S&P 500, Nasdaq 100 Drive into Correction Territory
JournalArta
JournalArta
·
२१ मिनेट पहिले
Target and Genmab Show Strength as S&P 500 Falls
About P3 Health Partners Inc
CEO-
Employees३२०
Founded२०२०
Headquartersहेंडरसन, नेवाडा, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitep3hp.org
Analyst ratings
Based on 2 analysts giving stock ratings to PIII in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PIII in the last 3 months.
Highest
Current US$ १.६९
US$ ११.५० (+५८०.४७%)
Average
US$ ७.७५ (+३५८.५८%)
Lowest
US$ ४.०० (+१३६.६९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Hold
Reiterated
US$ ४.००
+१३६.७%
11/11/2026
Gary Taylor
TD Cowen
Hold
Reiterated
US$ ४.००
+१३६.७%
11/11/2026
Ben Haynor
Lake Street
Buy
Maintained
US$ ११.५०
+५८०.५%
11/10/2026
Daniel Brims
Lake Street
Buy
Reiterated
US$ ९६२.००
+५६,८२३.१%
05/15/2026
David Larsen
BTIG
Hold
Reiterated
-
-
11/14/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
३८.४८ करोड
३८.६४ करोड
३८.६४ करोड
३९.६३ करोड
Cost of goods sold
४२.६१ करोड
३३.६० करोड
३०.०४ करोड
३४.६० करोड
Cost of revenue
४२.६१ करोड
३३.६० करोड
३०.०४ करोड
३४.६० करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.६२ करोड
२.५८ करोड
३.२४ करोड
३.४३ करोड
Operating expense
११.२६ करोड
४.२१ करोड
४.४८ करोड
२.७४ करोड
Total operating expenses
५३.८७ करोड
३७.८२ करोड
३४.५२ करोड
३७.३४ करोड
Operating income
-१५.३९ करोड
८२.३७ लाख
४.१२ करोड
२.३० करोड
Other non operating income
२९.११ लाख
५.७२ लाख
-१.६४ करोड
१.२९ करोड
EBT including unusual items
-१६.६८ करोड
-७९.५७ लाख
१.६९ करोड
३.०८ करोड
EBT excluding unusual items
-१६.६६ करोड
-७९.५७ लाख
१.६९ करोड
३.०८ करोड
Income tax expense
-१०.४० लाख
-१.१० करोड
१२.६५ लाख
२३.०० हजार
Effective tax rate
०.६२%
१३८.२१%
७.४८%
०.०७%
Other operating expenses
५.५४ करोड
-४७.१५ लाख
-८६.५९ लाख
-२.८० करोड
Net income
-७.५५ करोड
१२.२३ लाख
७४.४४ लाख
१.५६ करोड
Net profit margin
-१९.६२%
०.३२%
१.९३%
३.९४%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-१.५६ करोड
-१.६८ करोड
-७८.६२ लाख
-५०.४२ लाख
Net interest expenses
-१.५६ करोड
-१.६८ करोड
-७८.६२ लाख
-५०.४२ लाख
Depreciation and amortization charges
२.१० करोड
२.११ करोड
२.१० करोड
२.१० करोड
EBITDA
-१३.२९ करोड
२.९३ करोड
६.२३ करोड
४.४० करोड
Gain or loss from assets sale
-१.७८ लाख
-
१.२७ लाख
२५.०० हजार
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू